S. Adi

612 total citations
12 papers, 504 citations indexed

About

S. Adi is a scholar working on Molecular Biology, Epidemiology and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, S. Adi has authored 12 papers receiving a total of 504 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Molecular Biology, 4 papers in Epidemiology and 4 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in S. Adi's work include Peroxisome Proliferator-Activated Receptors (4 papers), Fatty Acid Research and Health (4 papers) and Liver Disease Diagnosis and Treatment (3 papers). S. Adi is often cited by papers focused on Peroxisome Proliferator-Activated Receptors (4 papers), Fatty Acid Research and Health (4 papers) and Liver Disease Diagnosis and Treatment (3 papers). S. Adi collaborates with scholars based in United States and Israel. S. Adi's co-authors include Carl Grünfeld, Kenneth R. Feingold, Arthur H. Moser, Mounzer Soued, William T. Doerrler, Judy K. Shigenaga, Walter Fiers, C A Dinarello, Ilona Staprãns and Richard A. Neese and has published in prestigious journals such as Journal of Clinical Investigation, Endocrinology and Diabetologia.

In The Last Decade

S. Adi

11 papers receiving 498 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
S. Adi United States 10 140 136 134 127 116 12 504
Mitsue Sogawa Japan 16 114 0.8× 142 1.0× 69 0.5× 333 2.6× 131 1.1× 43 747
Christine Mathews United States 5 90 0.6× 120 0.9× 75 0.6× 111 0.9× 70 0.6× 7 460
Susanna Vikman United States 8 196 1.4× 65 0.5× 187 1.4× 48 0.4× 83 0.7× 8 623
Ndeye Coumba Ndiaye France 15 175 1.3× 90 0.7× 73 0.5× 50 0.4× 77 0.7× 35 555
Mariko Wada Japan 12 206 1.5× 41 0.3× 88 0.7× 108 0.9× 58 0.5× 19 590
C M Asplin United Kingdom 13 107 0.8× 175 1.3× 268 2.0× 178 1.4× 113 1.0× 27 707
Didier Chevenne France 12 193 1.4× 130 1.0× 146 1.1× 82 0.6× 25 0.2× 30 598
Saskia N. van der Crabben Netherlands 8 149 1.1× 146 1.1× 189 1.4× 49 0.4× 75 0.6× 12 609
Henning Jansen Germany 11 98 0.7× 64 0.5× 83 0.6× 115 0.9× 46 0.4× 31 427
Yun Huang China 16 181 1.3× 76 0.6× 164 1.2× 123 1.0× 57 0.5× 40 649

Countries citing papers authored by S. Adi

Since Specialization
Citations

This map shows the geographic impact of S. Adi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by S. Adi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites S. Adi more than expected).

Fields of papers citing papers by S. Adi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by S. Adi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by S. Adi. The network helps show where S. Adi may publish in the future.

Co-authorship network of co-authors of S. Adi

This figure shows the co-authorship network connecting the top 25 collaborators of S. Adi. A scholar is included among the top collaborators of S. Adi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with S. Adi. S. Adi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

12 of 12 papers shown
1.
Kanner, Joseph, S. Adi, & Oren Tirosh. (2025). Ferroptosis: The Initiation Process of Lipid Peroxidation in Muscle Food. Antioxidants. 14(10). 1157–1157.
2.
Adi, S., et al.. (2013). Combined Pancreatic Islet and Kidney Transplantation in a Child With Unstable Type 1 Diabetes and End-Stage Renal Disease. American Journal of Transplantation. 13(8). 2207–2210. 3 indexed citations
3.
Herold, Kevan C., Stephen E. Gitelman, Steven M. Willi, et al.. (2012). Teplizumab treatment may improve C-peptide responses in participants with type 1 diabetes after the new-onset period: a randomised controlled trial. Diabetologia. 56(2). 391–400. 111 indexed citations
5.
6.
Adi, S., et al.. (2000). Functional inactivation of the IGF-I receptor delays differentiation of skeletal muscle cells. Journal of Endocrinology. 167(1). 175–182. 25 indexed citations
7.
Adi, S., Allan S. Pollock, Judy K. Shigenaga, et al.. (1992). Role for monokines in the metabolic effects of endotoxin. Interferon-gamma restores responsiveness of C3H/HeJ mice in vivo.. Journal of Clinical Investigation. 89(5). 1603–1609. 49 indexed citations
8.
Memon, Riaz A., Kenneth R. Feingold, Arthur H. Moser, et al.. (1992). Differential effects of interleukin-1 and tumor necrosis factor on ketogenesis. American Journal of Physiology-Endocrinology and Metabolism. 263(2). E301–E309. 54 indexed citations
9.
Grünfeld, Carl, Mounzer Soued, S. Adi, et al.. (1991). Interleukin 4 inhibits stimulation of hepatic lipogenesis by tumor necrosis factor, interleukin 1, and interleukin 6 but not by interferon-alpha.. PubMed. 51(11). 2803–7. 41 indexed citations
10.
Feingold, Kenneth R., Mounzer Soued, S. Adi, et al.. (1991). Effect of interleukin-1 on lipid metabolism in the rat. Similarities to and differences from tumor necrosis factor.. Arteriosclerosis and Thrombosis A Journal of Vascular Biology. 11(3). 495–500. 79 indexed citations
11.
Grünfeld, Carl, S. Adi, Mounzer Soued, et al.. (1990). Search for mediators of the lipogenic effects of tumor necrosis factor: potential role for interleukin 6.. PubMed. 50(14). 4233–8. 58 indexed citations
12.
Feingold, Kenneth R., S. Adi, Ilona Staprãns, et al.. (1990). Diet affects the mechanisms by which TNF stimulates hepatic triglyceride production. American Journal of Physiology-Endocrinology and Metabolism. 259(2). E177–E184. 53 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026